MeSH tree: N06.850.520.450
A single dose of the psychedelic drug dimethyltryptamine (DMT), given with psychological support, rapidly reduced depressive symptoms in 34 adults with major depressive disorder, according to a clinical trial published in ...
Feb 17, 2026
0
97
Hiroshima University researchers developed a three-factor, 12-item, questionnaire-based scale to systematically assess nursing practices that support fertility preservation decision-making in women with cancer. They show ...
Feb 2, 2026
0
3
"DJ S-Low" leaned intently over a glowing digital controller, headphones on and head bobbing, as she mixed two tracks by New Order into one seamless transition.
Jan 29, 2026
0
8
In Ontario, primary care home visits, which help older adults who are homebound or have difficulty getting to a clinic, increased during the 2010s but declined after a 2019 policy change reduced payment incentives and the ...
Jan 27, 2026
0
11
Spinal metastasis, the spread of cancer to the spine, is a frequent complication in advanced cancer. It often causes severe pain and paralysis, significantly impacting quality of life.
Jan 26, 2026
0
11
Memantine, a long-approved and cost-effective drug used to treat Alzheimer's disease, could also benefit patients with sickle cell anemia in the future. Initial clinical data from an international research group led by the ...
Jan 15, 2026
0
9
Griffith University researchers may have unlocked the secret to treating sepsis, with a Phase II clinical trial in China successfully concluding with promising results.
Jan 15, 2026
0
13
Maternal influenza and tetanus-diphtheria-acellular pertussis (Tdap) vaccinations are associated with a lower risk for influenza- and pertussis-related hospitalization or emergency department (ED) visits in infants younger ...
Jan 9, 2026
0
12
A new study has found that insufficient dietary lycopene intake is associated with a significantly higher risk of severe periodontitis among U.S. adults ages 65 to 79, with differences in risk patterns observed across race ...
Jan 8, 2026
0
406
A team of scientists and physicians at Mass General Brigham has developed a single-dose oral cholera vaccine and tested it in a phase 1 clinical trial, with results published in The Lancet Infectious Diseases.
Jan 7, 2026
0
21
